{"url_path":"/sec/kura/8-k/2026-06-04/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1422143/0001193125-26-257368-index.html","accession_number":"0001193125-26-257368","cik":"0001422143","ticker":"KURA","issuer_name":"Kura Oncology, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1422143/0001193125-26-257368-index.html","primary_entity_key":"0001422143","primary_entity_name":"Kura Oncology, Inc."},"word_count":185,"has_tables":true,"body_markdown":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.\n\n(e) On April 9, 2026, our Board of Directors (the “Board”), upon the recommendation of the Compensation Committee of the Board, amended the Kura Oncology, Inc. Amended and Restated 2014 Equity Incentive Plan (the “2014 Plan”) and the 2015 Employee Stock Purchase Plan (the “ESPP”), in each case subject to stockholder approval, to, among other things, increase the number of shares of our common stock authorized for issuance under the 2014 Plan by 6,500,000 shares (the “Amended 2014 Plan”) and increase the number of shares of our common stock authorized for issuance under the ESPP by 2,500,000 shares (the “Amended ESPP”), respectively. On June 4, 2026, our stockholders approved the Amended 2014 Plan and the Amended ESPP.\n\nComplete copies of the Amended 2014 Plan and the Amended ESPP are filed herewith as Exhibit 99.1 and 99.2, respectively. The above summaries of the Amended 2014 Plan and Amended ESPP do not purport to be complete and are qualified in their entirety by reference to such exhibits."}